Show Notes
You may have seen the headlines about lead in protein powders and probably are concerned. Before you throw out your tub, let's cut through the noise. We'll look at what the Consumer Reports investigation actually found, compare the different safety standards (FDA vs. Prop 65), and give you a practical framework to decide what's right for you.
Stop stressing over every health detail & start living! My FREE 'Necessary Nine' PDF cuts through the noise, giving you the essential things you need for a healthy life.
➡️ Download Here: https://www.jrennickemd.com/necessaryninepdf
CHAPTERS:
00:00 - Intro
00:42 - What Did the Consumer Reports Investigation Do?
01:24 - The Benchmark: How Consumer Reports Measured Lead
02:01 - Understanding California's Proposition 65 (Prop 65)
02:26 - The Main Takeaway: How Many Powders Had High Lead?
02:46 - The Worst Offenders: Naked Nutrition & Huel
04:06 - The Plant-Based Problem: Why Pea Protein Absorbs Lead
04:58 - Does an "Organic" Label Mean It's Safe From Lead?
06:01 - Other Heavy Metals Found: Cadmium & Arsenic
06:23 - Why Is Lead a Problem? (No Known Safe Level)
07:07 - The Real Danger: Chronic Low-Level Exposure
08:06 - Who is Most at Risk from Lead Exposure?
09:23 - The Gray Area: Why Huel & Consumer Reports Both Say They're "Right"
09:39 - How the FDA Regulates Supplements (or Doesn't)
10:39 - Prop 65 is a "Right to Know" Law, Not a Safety Law
11:38 - How the Prop 65 Limit is Set (A 1000x Safety Margin)
13:02 - Prop 65 vs. The FDA's Benchmark (Interim Reference Levels)
15:18 - Protein Powders vs. Whole Foods: Comparing Lead Levels
16:29 - The "Concentration Effect": Why Processing Increases Risk
17:18 - Practical Takeaways: What Can We Do?
17:30 - Big Rock 1: Re-evaluate & Prioritize Moderation
18:45 - Big Rock 2: Be an Informed Consumer (Whey vs. Plant-Based)
20:11 - Big Rock 3: Look for Third-Party Certifications (NSF, USP)
21:26 - My Final Thoughts: Don't Freak Out, Be Informed
SELECTED REFERENCES:
https://www.fda.gov/food/environmental-contaminants-food/lead-food-and-foodwares
https://www.gov.mb.ca/health/publichealth/factsheets/lead_factsheet.pdf
https://www.p65warnings.ca.gov/
Disclaimer
This podcast is for entertainment, education, and informational purposes only.
The topics discussed should not solely be used to diagnose, treat , or prevent any condition.
The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate.
Always seek the advice of your personal physician or qualified health care provider for questions regarding any medical condition
More from Building Lifelong Athletes
In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.
Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.
In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.
Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.